Mark C. Schneyer
EVP, CHIEF FINANCIAL OFFICER · ACADIA PHARMACEUTICALS INC
- 2024
- Aug 7, 2026
- 12
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mark C. Schneyer files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- James M. Daly - $671K in ACAD purchases and sales in the last 12 months
- James Kihara - $603K in ACAD purchases and sales in the last 12 months
- Elizabeth H.Z. Thompson - $506K in ACAD purchases and sales in the last 12 months
- Adams Catherine Owen - $250K in ACAD purchases and sales in the last 12 months
- Jennifer J. Rhodes - $245K in ACAD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mark C. Schneyer?
Mark C. Schneyer is a corporate insider, tracked as EVP, CHIEF FINANCIAL OFFICER of ACADIA PHARMACEUTICALS INC (ACAD). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Mark C. Schneyer submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Mark C. Schneyer been buying or selling stock?
Recorded transactions: 0 open-market purchases and 15 open-market sales ($2.08M) across all tracked filings.
